Back to search results
NCT06424769

Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management

Enrolling by Invitation
NAAges 13+InterventionalSupportive care
University of North Carolina, Chapel Hill
~900 participants
Updated 2026-07-08 on ClinicalTrials.gov
What's tested:Enhanced Digital CareEducation

At a glance

Recruiting sites
0 of 9 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Patient Activation using PAM
Measured over Baseline, 12 months

Conditions

Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis
Colitis

Explore related trials

Colitis of Indeterminate TypeCrohn DiseaseInflammatory Bowel DiseaseUlcerative Colitis

Where it's being run

9 sites across 7 states
California2
North Carolina2
Arizona1
Georgia1
Massachusetts1
New York1
Pennsylvania1

Study leadership

  • Michael D Kappelman, MD, MPH · PRINCIPAL_INVESTIGATOR · University of North Carolina, Chapel Hill
  • Siddharth Singh, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

13+ years old with IBD (Crohn's disease, ulcerative colitis, indeterminant colitis).
Followed at a participating site with an office visit (in-person or virtual) within the preceding 12 months.
Have access to a mobile phone and willing and able to receive and respond to text messages.
Willing to answer questions on electronic surveys.
Have the ability to read text messages and answer surveys in English or Spanish.

Exclusion

IBD patients s/p surgery with a current pouch or ostomy.
Unable to provide informed consent and child assent for minors.

What this trial measures

  • Change in Patient Activation using PAMBaseline, 12 months

    The primary outcome is the change in patient activation from baseline, with a 4-point improvement on Patient Activation Measure (PAM) scale considered a minimal clinically important difference (MCID). Patient activation is an assessment of the knowledge, skills and confidence of patients to manage their health. In chronic diseases, activated patients are more likely to adhere to treatment, perform regular self-monitoring at home and obtain regular chronic care. Activated patients are also more likely to make healthier lifestyle choices and preventative behaviors. Longitudinal improvement in patient activation measures is associated with improved clinical outcomes, decreased unplanned healthcare utilization and lower costs.